Group 1 - The core point of the article is that Jindawei has received a patent for a coenzyme Q10 oil preparation method, which may enhance its product offerings and market position [1] - Jindawei's revenue composition for the first half of 2025 shows that industrial revenue accounts for 98.5%, pharmaceutical raw materials for 1.43%, and other businesses for 0.07% [1] - As of the report, Jindawei's market capitalization stands at 11.4 billion yuan [1]

（文章来源：每日经济新闻） 2024年1至12月份，金达威的营业收入构成为：工业占比97.88%，医药原料占比1.94%，其他业务占比 0.18%。 金达威（SZ 002626，收盘价：20.31元）8月5日晚间发布公告称，公司第九届第三次董事会会议于2025 年8月5日在厦门市海沧区公司五层会议室以现场结合通讯表决的方式召开。会议审议了《关于调整公司 向不特定对象发行可转换公司债券募集资金规模的议案》等文件。 ...